About Gelesis

Gelesis is a clinical stage biotechnology company developing first-in-class therapeutics to safely treat obese, overweight, and diabetic patients. Gelesis100, our lead product, is an orally- administered smart pill which is constructed of materials that are General Recognized as Safe (GRAS) by the Food and Drug Administration (FDA). Each Gelesis100 capsule contains thousands of hydrogel particles approximately the size of a grain of salt that expand to 100 times their dry weight. The pill is des

Repeat Founder
Company Highlights
Year Founded

2006

icon-altEmployees

57

Location (HQ)

USA

Since Last Funding

2 years 8 months

Monthly Website Visitors

7.2K

icon-altTotal Investment Amt

$300M

Last Funding Round

Post Ipo Debt

icon-altMoM Headcount Growth

1.78%

icon-altYoY Headcount Growth

-8.05%

Key Metrics

Senior Hires

NameLinkedin ProfilePositionDate Joined
John Doehttps://www.linkedin.com/in/johndoeCEOCEO
Jane Doehttps://www.linkedin.com/in/janedoeCTOCTO
John Smithhttps://www.linkedin.com/in/johnsmithCFOCFO
Jane Smithhttps://www.linkedin.com/in/janesmithCOOCOO
Get API access to complete private company database with growth metrics from 15 sources

Similar Companies

Health Care

Biotechnology

Biotechnology Research

Medical Device

Diabetes